Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model
- Cost-Effectiveness of Rotavirus Vaccination in Peru. Clark, Andrew D.; Walker, Damian G.; Mosqueira, N. Rocio; Penny, Mary E.; Lanata, Claudio F.; Fox-Rushby, Julia; Sanderso, Colin F. B. // Journal of Infectious Diseases;11/2/2009, Vol. 200 Issue S1, pS114
Background. There are plans to introduce the oral rotavirus vaccine Rotarix (GlaxoSmithKline), 1 of 2 recently developed vaccines against rotavirus, in Peru. Methods. We modeled the cost-effectiveness of adding a rotavirus vaccine to the Peruvian immunization program under 3 scenarios for the...
- Reviewing the Cost Effectiveness of Rotavirus Vaccination. Bilcke, Joke; Beutels, Philippe // PharmacoEconomics;2009, Vol. 27 Issue 4, p281
Published health economic evaluations of rotavirus vaccination up until July 2008 were reviewed. We assess whether differences in the results and conclusions of the various studies are due to differences in methodological and modelling choices, and/or the way parameter uncertainty was taken into...
- Rotavirus vaccination not economically viable in Thailand. // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p9
The article discusses a study on the cost-effectiveness of infant rotavirus vaccination in Thailand.
- Chinese study: Universal rotavirus immunization may be cost-effective. // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p36
This article focuses on a study which examined the cost-effectiveness of rotavirus immunization in China.
- Rotavirus vax should be "highly cost-effective" in Bolivia. // PharmacoEconomics & Outcomes News;7/9/2011, Issue 632, p5
This article summarizes a report on the cost effectiveness of universal rotavirus vaccination in Bolivia.
- Re: “Age Dependence of the Risk of Intussusception Following Tetravalent Rhesus-Human Reassortant Rotavirus Tetravalent Vaccine: Is it Beyond Doubt?”. // American Journal of Epidemiology;Jul2010, Vol. 172 Issue 1, p125
A correction to the article "Age Dependence of the Risk of Intussusception Following Tetravalent Rhesus-Human Reassortant Rotavirus Tetravalent Vaccine: Is It Beyond Doubt?" by J. Chen, J. F. Heyse, P. Heaton and colleagues, is presented.
- Vaccine success cuts rotavirus illness. Ratcliffe, Lucy // New Zealand Doctor;3/13/2013, p11
The article reports on the 71% decrease in hospitalization incidence of patients with rotavirus due to the rotavirus vaccines Rotarix and Rotateq in Australasia.
- Rotavirus vax economically sound in England and Wales. // PharmacoEconomics & Outcomes News;10/13/2012, Issue 664, p1
The article discusses research on the cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. It references a study by K. E. Atkins and colleagues published in the September 20, 2012 issue of "Vaccine." A 50-year dynamic transmission model to compare the cost effectiveness...
- Rotavirus vaccination not currently cost effective for kids in France. // PharmacoEconomics & Outcomes News;1/26/2008, Issue 545, p4
The article discusses a research on the costs and cost-effectiveness of childhood vaccination against rotavirus in France. It references a study by H. Melliez and colleagues, published in the January 2008 issue of "Vaccine." The study found that rotavirus vaccination reduces hospitalizations and...